Why longevity matters to everyone: Living longer lives in the world of Web3
2022.07.02 21:56
Why longevity matters to everyone: Living longer lives in the world of Web3
Expected to reach a market size of $128 billion by 2028, the longevity sector is no longer something that those outside the medical world can ignore. In the next few years, life-extending technologies and treatments for aging-related diseases will reach human trials. There is an exciting wave of development happening in research labs and technology centers across the globe, with more and more early adopters embarking on their longevity journeys.
As I’ve remarked in my earlier article, the crypto community would do well to learn more and engage in the growing longevity field. Longevity not only incorporates disruptive technologies, such as artificial intelligence and distributed ledger technologies but also has a visionary spirit and is supported by stakeholders dedicated to improving the human aging experience.
Garri Zmudze is a managing partner at LongeVC, a Switzerland- and Cyprus-based venture capital firm accelerating innovative startups in biotech and longevity. He is a seasoned business expert and angel investor with several successful exits across biotech and tech companies. He is a long-time supporter and investor in biotech companies, including Insilico Medicine, Deep Longevity and Basepaws.
